Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment

The Lancet

Volumn 338, Issue 8769, 1991, Pages 725-726

  Valerius, N H ^a   Koch, C ^a   H o iby, N ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; COLISTIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG INFECTION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CIPROFLOXACIN; COLISTIN; CYSTIC FIBROSIS; DRUG THERAPY, COMBINATION; FEMALE; HUMAN; INFANT; MALE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SPUTUM;

EID: 0025868478     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(91)91446-2     Document Type: Article

References (9)

1. Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection
2. Nebulised colimycin for early Pseudomonas colonisation in cystic fibrosis
3. Antibacterial therapy in cystic fibrosis. A review of the literature published between 1980 and February 1987
4. Antibiotic therapy for bronchopulmonary infections in cystic fibrosis. The American approach. Pseudomonas aeruginosa infection
5. Antimicrobial chemotherapy in cystic fibrosis patients
6. Pseudomonas aeruginosa infection in cystic fibrosis
7. Antibiotic treatment. Aerosol therapy
8. Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection
9. Efficacy of oral fluoroquinolones versus conventional intravenous antipseudomonal chemotherapy in treatment of cystic fibrosis